|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses, current | ||||||||||||||||||||
| Restricted cash, current | ||||||||||||||||||||
| Other assets, current | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Lease right-of-use assets, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Restricted cash, long-term | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Prepaid expenses and other, long-term | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accrued in-licensed rights, current | ||||||||||||||||||||
| Lease liabilities, current | ||||||||||||||||||||
| Post-marketing commitment liability | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Other liabilities, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Lease liabilities, long-term | ||||||||||||||||||||
| Post-marketing commitment liability, long-term | ||||||||||||||||||||
| Total long-term debt, net | ||||||||||||||||||||
| Other liabilities, long-term | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock - $0.0001 par value per share; 100,000,000 shares authorized; 51,102,687 shares issued and outstanding at June 30, 2026 and 50,408,023 issued and outstanding at December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
